Back to search

Article

Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells

2024-03-16

Abstract excerpt

Glioblastoma (GBM) tumors represents diverse genomic epigenomic, and transcriptional landscapes, with significant intratumoral heterogeneity that challenges standard of care treatments involving radiation (RT) and the DNA-alkylating agent temozolomide (TMZ). In this study, we employed targeted proteomics to assess the response of a genomically-diverse panel of GBM patient-derived cancer stem cells (CSCs) to astroc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5a576ca1-e709-51ce-a14d-474691f891bb
DOI
10.1101/2024.03.14.585115
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cellsDOI 10.1101/2024.03.14.585115
Select a neighboring publication to make it the new centre.